PFAS (“Forever Chemicals”) Test Panel from Quest Health

quest-health-discovery-eb8f3bebd86fe50ad3c8c14c0f39 measurement quality: The lab work itself is performed by Quest Diagnostics' CLIA-certified laboratories, ensuring the same quality as physician-ordered tests. The exact offer page identifies the panel's named measurements and collection route, while exact facility, assay method, and offer-specific analytical performance remain unpublished. Evidence status partial maps to partial. The provider-wide Quest Diagnostics CLIA laboratory evidence supports a plausible approach, but the exact facility, assay method, and offer-level performance remain unpublished, Limitation: Quest Diagnostics CLIA laboratory system is identified, but exact facility, exact assay method, and offer-specific analytical performance are not published.

quest-health-discovery-eb8f3bebd86fe50ad3c8c14c0f39 target relevance: The page describes the test purpose for PFAS (“Forever Chemicals”) Test Panel. Evidence status supported maps to confirmed. The retained exact-offer excerpt gives a direct purpose statement without a more detailed association or action boundary, scoring in the lower 80s on confirmed evidence. Limitation: The saved evidence supports this dimension with bounded scope.

quest-health-discovery-eb8f3bebd86fe50ad3c8c14c0f39 coverage: The page names the measured components. Evidence status partial maps to partial. The retained exact-offer excerpt only states that measured components are named, scoring in the lower 70s on partial evidence. Limitation: Rendered text may abbreviate the full measurement list.

quest-health-discovery-eb8f3bebd86fe50ad3c8c14c0f39 interpretability: clear, easy-to-read report. If you have, or create, a MyQuest® account, your results may also be available there;and for larger panel tests, you may be able to see individual. Evidence status supported maps to confirmed. The exact-offer evidence identifies a clear report and MyQuest result access, supporting a middle 80s score on confirmed evidence. Limitation: The saved evidence supports this dimension with bounded scope.

quest-health-discovery-eb8f3bebd86fe50ad3c8c14c0f39 transparency: Provider terms: a $20 non-refundable cancellation fee per order covers the Prescriptive Authority Provider; purchases expire 60 days after purchase if the sample is not collected; refunds process within 7-14 business days. Evidence status partial maps to partial. The retained provider-wide terms disclose cancellation, expiry, and refund conditions, but do not supply offer-specific method and laboratory details, scoring in the middle 70s on partial evidence. Limitation: Provider-wide terms, not per-offer.

quest-health-discovery-eb8f3bebd86fe50ad3c8c14c0f39 practical access: Buy online with no doctor visit required; register the test; visit a Quest Patient Service Center or use Quest Mobile in-home collection where available. Not available in Arizona, Hawaii. Evidence status supported maps to confirmed. The exact-offer evidence states online purchase, Quest collection, and Quest Mobile where available, with state and local availability limits, scoring in the upper 70s on confirmed evidence. Limitation: The saved evidence supports this dimension with bounded scope.

quest-health-discovery-eb8f3bebd86fe50ad3c8c14c0f39 cost and terms: Exact-offer price $350.00 plus a $6.00 Physician Service Fee; HSA/FSA cards accepted at checkout but individual eligibility is not confirmed. Evidence status supported maps to confirmed. The confirmed exact-offer price is 350.00 USD plus the 6.00 USD physician fee, or 356.00 USD before any other buyer-specific cost. Its deterministic cost tier is over 256 USD; a score in the 70s remains appropriate because HSA or FSA eligibility is not confirmed. Limitation: Eligibility of HSA/FSA funds is not confirmed.

quest-health-discovery-eb8f3bebd86fe50ad3c8c14c0f39 privacy: Quest Consumer is not a HIPAA covered service; the privacy notice describes collection, use, and sharing with affiliates and third parties. Evidence status partial maps to partial. The provider-wide privacy evidence covers collection, use, and sharing with affiliates and third parties, but no per-offer retention period is published, scoring in the middle 70s on partial evidence. Limitation: Provider-wide notice, not per-offer.